Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity
Molecules · 2025
DOI: 10.3390/molecules30122580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Gyuri Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, CMRI, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Platelet Aggregation, Chalcones, Thrombin, Fibrinolytic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT).
Abstract (Originalsprache)
Naturally occurring plant-based compounds are increasingly being explored for their therapeutic potential in treating a wide range of conditions, particularly those related to vascular health. The compound 3-deoxysappanchalcone (3-DSC), derived from Caesalpinia sappan L., has been proven to exhibit anti-inflammatory, anti-influenza, and anti-allergic properties, though its role in thrombosis and haemostasis remains unexplored. This study aimed to evaluate the anti-thrombotic potential of 3-DSC in both in vitro and in vivo models. The anticoagulant activities of 3-DSC were assessed using activated partial thromboplastin time (aPTT), prothrombin time (PT), and thrombin (FIIa) and activated factor X (FXa) activity assays, as well as fibrin polymerization and platelet aggregation tests. Its effects on plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) expression were evaluated in TNF-α-stimulated human umbilical vein endothelial cells (HUVECs). The results demonstrated that 3-DSC extended aPTT and PT, suppressed thrombin and FXa activities, reduced their production in HUVECs, inhibited thrombin-induced fibrin polymerization and platelet aggregation, and exerted anticoagulant effects in mice. Furthermore, 3-DSC significantly decreased the PAI-1 to t-PA ratio. These findings suggest that 3-DSC possesses potent anti-thrombotic properties by modulating coagulation pathways and fibrinolysis. Its therapeutic potential warrants further investigation for the development of novel anticoagulant agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Pharmaceutical Sciences, CMRI, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea.
ORCID-Profile: Jong-Sup Bae
Förderung
- This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
- National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
Zitieren
APA
Han, G., Lee, J., & Bae, J. S. (2025). Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity. Molecules. https://doi.org/10.3390/molecules30122580
Vancouver
Han G, Lee J, Bae JS. Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity. Molecules. 2025. doi:10.3390/molecules30122580
BibTeX
@article{Han2025,
author = {Han, Gyuri and Lee, Jinhee and Bae, Jong-Sup},
title = {Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30122580}
}
EUVIMED